SCHEMBL6753817

SCHEMBL6753817

CC(C)(C)OC(=O)NC1CCC(Nc2nc(N(Cc3ccccc3)C3CCNCC3)c3ncn(C4CCCC4)c3n2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 13/20 0.45
▸ CDK1 P06493 11/20 0.45
▸ CCNE1 P24864 11/20 0.45
▸ CCNE2 O96020 4/20 0.45
▸ FLT3 P36888 4/20 0.45
▸ CCNB2 O95067 3/20 0.45
▸ CDK4 P11802 3/20 0.45
▸ CCNB1 P14635 3/20 0.45
▸ CCND1 P24385 3/20 0.45
▸ CCNB3 Q8WWL7 3/20 0.45
▸ PDGFRA P16234 5/20 0.41
▸ SRC P12931 2/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ CCNA2 P20248 1/20 0.41
▸ CCNA1 P78396 1/20 0.41
▸ JAK1 P23458 1/20 0.38
▸ CCNT1 O60563 1/20 0.38
▸ CDK7 P50613 1/20 0.38
▸ CDK9 P50750 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6753818 1.00 CDK2 (0.45) CDK2CDK1CCNE1CCNE2FLT3
SCHEMBL6753756 0.90 KMT2A (0.35) CDK2CDK1CCNE1CCNE2FLT3
SCHEMBL6751476 0.88 CCNE2 (0.48) CDK2CDK1CCNE1CCNE2CCNA2
SCHEMBL6751475 0.88 CCNE2 (0.48) CDK2CDK1CCNE1CCNE2CCNA2
SCHEMBL4372748 0.81 CDK2 (0.49) CDK2CDK1CCNE1CCNE2FLT3
SCHEMBL4372753 0.81 CDK2 (0.49) CDK2CDK1CCNE1CCNE2FLT3
SCHEMBL4372495 0.78 FLT3 (0.55) CDK2CDK1CCNE1CCNE2FLT3
SCHEMBL4372328 0.78 FLT3 (0.55) CDK2CDK1CCNE1CCNE2FLT3
SCHEMBL4372504 0.71 MERTK (0.39) CDK2FLT3PDGFRACCNA2JAK1
SCHEMBL4372507 0.71 MERTK (0.39) CDK2FLT3PDGFRACCNA2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1377579-A2 ACYL AND SULFONYL DERIVATIVES OF 6,9-DISUBSTITUTED 2-(TRANS-1,4-DIAMINOCYCLOHEXYL)-PURINES AND THEIR USE AS ANTIPROLIFERATIVE AGENTS Aventis Pharmaceuticals Inc. (US) 2004-01-07 — — EP disclosed
WO-2002042303-A2 ACYL AND SULFONYL DERIVATIVES OF 6,9-DISUBSTITUTED 2-(TRANS-1,4-DIAMINOCYCLOHEXYL)-PURINES AND THEIR USE AS ANTIPROLIFERATIVE AGENTS AVENTIS PHARMACEUTICALS INC. (US) 2002-05-30 — — WO disclosed
Send feedback